{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T14:10:37Z","timestamp":1791468637441,"version":"4.3.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100013077","name":"National Science and Technology Planning Project","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013077","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.phymed.2020.153270","type":"journal-article","created":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T07:07:12Z","timestamp":1592636832000},"page":"153270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["The water extract of Sophorae tonkinensis Radix et Rhizoma alleviates non-alcoholic fatty liver disease and its mechanism"],"prefix":"10.1016","volume":"77","author":[{"given":"Qing","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjuan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaobo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenlin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6159-2626","authenticated-orcid":false,"given":"Lili","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2020.153270_bib0001","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/liv.13643","article-title":"Global epidemiology of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis: what we need in the future","volume":"1","author":"Araujo","year":"2018","journal-title":"Liver Int. Suppl."},{"key":"10.1016\/j.phymed.2020.153270_bib0002","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1007\/s10620-016-4049-x","article-title":"Innate immunity and inflammation in NAFLD\/NASH","volume":"61","author":"Arrese","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.phymed.2020.153270_bib0003","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/hep.27173","article-title":"Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease","volume":"60","author":"Bedossa","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2020.153270_bib0004","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.humpath.2004.04.017","article-title":"Nonalcoholic steatohepatitis : histologic features and clinical correlations with 30 blinded biopsy specimens","volume":"35","author":"Brunt","year":"2004","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.phymed.2020.153270_bib0005","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"issue":"1 Suppl","key":"10.1016\/j.phymed.2020.153270_bib0006","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD : a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2020.153270_bib0007","doi-asserted-by":"crossref","first-page":"E96","DOI":"10.3390\/nu9020096","article-title":"Effects of natural products on fructose-induced nonalcoholic fatty liver disease (NAFLD)","volume":"9","author":"Chen","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.phymed.2020.153270_bib0008","first-page":"2439","article-title":"Pharmacological effect and toxicology of Sophorae Tonkinensis Radix et Rhizoma","volume":"42","author":"Chen","year":"2017","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"10.1016\/j.phymed.2020.153270_bib0009","series-title":"Pharmacopeia of Thepeople's Republic of China (2015) Version","first-page":"27","year":"2015"},{"key":"10.1016\/j.phymed.2020.153270_bib0010","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jceh.2019.06.004","article-title":"Peroxisome proliferator-activated receptors and their agonists in nonalcoholic fatty liver disease","volume":"9","author":"Choudhary","year":"2019","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.phymed.2020.153270_bib0011","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1053\/j.gastro.2005.09.004","article-title":"NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis","volume":"129","author":"Dela Pena","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phymed.2020.153270_bib0012","first-page":"83","article-title":"Emerging therapeutic targets and experimental drugs for the treatement of NAFLD","volume":"6","author":"Dibba","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.phymed.2020.153270_bib0013","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2147\/HMER.S188991","article-title":"A review of current and upcoming treatment modalities in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis","volume":"11","author":"Ganguli","year":"2019","journal-title":"Hepat. Med."},{"key":"10.1016\/j.phymed.2020.153270_bib0014","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s12967-018-1685-2","article-title":"Matrine attenuates endoplasmic reticulum stress and mitochondrion dysfunction in nonalcoholic fatty liver disease by regulating SERCA pathway","volume":"16","author":"Gao","year":"2018","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.phymed.2020.153270_bib0015","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41419-018-1272-8","article-title":"Molecular mechanisms in the pathogenesis of N-nitrosodimethylamine induced hepatic fibrosis","volume":"10","author":"George","year":"2019","journal-title":"Cell Death. Dis."},{"key":"10.1016\/j.phymed.2020.153270_bib0016","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/s12072-019-09995-8","article-title":"Hepatocellular carcinoma and non-alcoholic fatty liver disease","volume":"13","author":"Golabi","year":"2019","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.phymed.2020.153270_bib0017","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev-physiol-021115-105045","article-title":"The biochemistry and physiology of mitochondrial fatty acid \u03b2-oxidation and its genetic disorders","volume":"78","author":"Houten","year":"2016","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.phymed.2020.153270_bib0018","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s10620-015-3977-1","article-title":"Animal models of nonalcoholic steatohepatitis : eat, delete, and inflame","volume":"61","author":"Ibrahim","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.phymed.2020.153270_bib0019","first-page":"2683","article-title":"Morphological and functional characterization of non-alcoholic fatty liver disease induced by a methionine-choline-deficient diet in C57BL\/6 mice","volume":"6","author":"Itagaki","year":"2013","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.phymed.2020.153270_bib0020","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2020.153270_bib0021","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s12272-019-01178-1","article-title":"Molecular insights into the role of mitochodnria in non-alcoholic fatty liver disease","volume":"42","author":"Lee","year":"2019","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.phymed.2020.153270_bib0022","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.3748\/wjg.v23.i11.1964","article-title":"Traditional Chinese herbal extracts inducing autophagy as a novel approach in therapy of nonalcoholic fatty liver disease","volume":"23","author":"Liu","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.phymed.2020.153270_bib0023","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.2174\/1381612811319290003","article-title":"Cardiovascular and systemic risk in nonalcoholic fatty liver disease-atherosclerosis as a major player in the natural course of NAFLD","volume":"19","author":"Lonardo","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.phymed.2020.153270_bib0024","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00018-003-3216-3","article-title":"Peroxisome proliferator-activated receptor alpha target genes","volume":"61","author":"Mandard","year":"2004","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.phymed.2020.153270_bib0025","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 inflammasome blockage reduces liver inflammation and fibrosis in experimental NASH in mice","volume":"66","author":"Mridha","year":"2017","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2020.153270_bib0026","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of PPAR\u03b1 action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2020.153270_bib0027","doi-asserted-by":"crossref","first-page":"e6796","DOI":"10.1371\/journal.pone.0006796","article-title":"Comparative analysis of gene regulation by the transcription factor PPARalpha between mouse and human","volume":"4","author":"Rakhshandehroo","year":"2009","journal-title":"PLoS ONE"},{"issue":"1 Suppl","key":"10.1016\/j.phymed.2020.153270_bib0028","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/0023677215570078","article-title":"Mouse models of metabolic liver injury","volume":"49","author":"Ramadori","year":"2015","journal-title":"Lab. Anim."},{"key":"10.1016\/j.phymed.2020.153270_bib0029","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s12072-019-10001-4","article-title":"New drugs for NAFLD : lessons from basic models to the clinic","volume":"14","author":"Reimer","year":"2020","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.phymed.2020.153270_bib0030","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1194\/jlr.M800042-JLR200","article-title":"Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet","volume":"49","author":"Rinella","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.phymed.2020.153270_bib0031","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cmet.2017.08.002","article-title":"Nonalcoholic fatty liver disease are a nexus of metabolic and hepatic diseases","volume":"27","author":"Samuel","year":"2018","journal-title":"Cell Metab."},{"key":"10.1016\/j.phymed.2020.153270_bib0032","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejphar.2013.06.013","volume":"714","author":"Shi","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phymed.2020.153270_bib0033","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jceh.2019.03.002","article-title":"Drug development for nonalcoholic fatty liver disease : landscape and challenges","volume":"9","author":"Thiagarajan","year":"2019","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.phymed.2020.153270_bib0034","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000443556","article-title":"Fatty Acid Beta-Oxidation Disorders: a Brief Review","volume":"23","author":"Vishwanath","year":"2016","journal-title":"Ann. Neurosci."},{"key":"10.1016\/j.phymed.2020.153270_bib0035","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.2174\/1389450116666150531155711","article-title":"Natural products on nonalcoholic fatty liver disease","volume":"16","author":"Xu","year":"2015","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.phymed.2020.153270_bib0036","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.3389\/fphar.2018.01459","article-title":"Herbal extracts and natural products in alleviating non-alcoholic fatty liver disease via activating autophagy","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Pharmacol."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S094471132030101X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S094471132030101X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T18:24:01Z","timestamp":1760552641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S094471132030101X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":36,"alternative-id":["S094471132030101X"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2020.153270","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The water extract of Sophorae tonkinensis Radix et Rhizoma alleviates non-alcoholic fatty liver disease and its mechanism","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2020.153270","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153270"}}